JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

Insulet Corp

Затворен

СекторЗдравеопазване

280.75 -2.33

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

280.27

Максимум

284.41

Ключови измерители

By Trading Economics

Приходи

-65M

35M

Продажби

-29M

569M

P/E

Средно за сектора

52.756

40.048

Марж на печалбата

6.221

Служители

3,900

EBITDA

-63M

79M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+20.4% upside

Дивиденти

By Dow Jones

Следващи печалби

7.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

837M

21B

Предишно отваряне

283.08

Предишно затваряне

280.75

Настроения в новините

By Acuity

22%

78%

49 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Weak Bearish Evidence

Insulet Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.08.2025 г., 23:11 ч. UTC

Печалби

Australia's REA Hikes Dividend as Annual Profit Rises 23% -- Update

5.08.2025 г., 22:45 ч. UTC

Печалби

Australia's REA Hikes Dividend as Annual Profit Rises 23%

5.08.2025 г., 22:39 ч. UTC

Печалби

Great-West Lifeco Logs Lower 2Q Profit

5.08.2025 г., 21:32 ч. UTC

Печалби

Coupang Posts Higher 2Q Sales Due to Customer Growth

6.08.2025 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

NFL to Take 10% Stake in Disney's ESPN -- WSJ

6.08.2025 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

The NFL Is Taking a 10% Stake in Disney's ESPN -- WSJ

6.08.2025 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

Disney to Take Control of NFL Network as Part of Agreement -- WSJ

6.08.2025 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

Disney, NFL Strike Wide-Reaching Media-Asset Deal -- WSJ

5.08.2025 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Decline Amid U.S. Economic Uncertainty -- Market Talk

5.08.2025 г., 23:40 ч. UTC

Пазарно говорене

Gold Edges Higher, Supported by Fed Rate-Cut Hopes -- Market Talk

5.08.2025 г., 23:19 ч. UTC

Пазарно говорене

Lindian Deal With Iluka Demonstrates Kangankunde Project Appeal -- Market Talk

5.08.2025 г., 23:03 ч. UTC

Пазарно говорене
Печалби

Advanced Micro Devices' Data-Center Story Seen as Promising -- Market Talk

5.08.2025 г., 22:22 ч. UTC

Печалби

REA: Expectation of More Interest-Rate Cuts Likely to Support Buyer Demand>REA.AU

5.08.2025 г., 22:21 ч. UTC

Печалби

REA Expects FY26 Listing Volumes Broadly Flat on FY25>REA.AU

5.08.2025 г., 22:20 ч. UTC

Печалби

REA Expects September-Quarter Listings to Be Down on Year>REA.AU

5.08.2025 г., 22:18 ч. UTC

Печалби

REA July 2025 New Residential Listings Down 8% on Year>REA.AU

5.08.2025 г., 22:17 ч. UTC

Печалби

REA FY25 Australian Residential Listings Up 1% on Year>REA.AU

5.08.2025 г., 22:17 ч. UTC

Печалби

REA FY25 India Revenue A$129M Vs. A$103M>REA.AU

5.08.2025 г., 22:16 ч. UTC

Печалби

REA FY25 Core Australia Revenue A$1.54B Vs. A$1.35B>REA.AU

5.08.2025 г., 22:16 ч. UTC

Печалби

REA FY25 Core Operations Net Profit A$564.4M Vs. A$460.5M>REA.AU

5.08.2025 г., 22:15 ч. UTC

Печалби

REA Group FY25 Ebitda A$969.2M Vs. A$824.8M>REA.AU

5.08.2025 г., 22:13 ч. UTC

Печалби

REA Group Raises Dividend to A$1.38 Vs. A$1.02 >REA.AU

5.08.2025 г., 22:13 ч. UTC

Печалби

REA Group FY25 Rev A$1.67B Vs. A$1.45B >REA.AU

5.08.2025 г., 22:12 ч. UTC

Печалби

REA FY25 Core Operations Net Profit A$564.4M Vs, A$460.5M>REA.AU

5.08.2025 г., 22:12 ч. UTC

Печалби

REA Group FY25 Net A$677.9M Vs. Net A$302.8M >REA.AU

5.08.2025 г., 21:58 ч. UTC

Печалби

Novo Nordisk's Earnings Come After a Dramatic Guidance Cut. What to Look for Now. -- Barrons.com

5.08.2025 г., 21:30 ч. UTC

Печалби

AMD Gives a Strong Outlook. Why the Stock Is Falling. -- Barrons.com

5.08.2025 г., 21:26 ч. UTC

Печалби

AMD CEO Expects Embedded Segment to Return to Sequential Growth in Back Half of 2025

5.08.2025 г., 21:23 ч. UTC

Печалби

AMD CEO Sees Strong Customer Interest in MI400 Series for Large-Scale Deployments

5.08.2025 г., 21:17 ч. UTC

Печалби

AMD Expects Steep Production Ramp for MI350 Series in Back Half of Year, CEO Says

Сравнение с други в отрасъла

Ценова промяна

Insulet Corp Прогноза

Ценова цел

By TipRanks

20.4% нагоре

12-месечна прогноза

Среден 338.33 USD  20.4%

Висок 380 USD

Нисък 266 USD

Според 22 анализатори от Wall Street, предложили 12-месечна ценова цел за Insulet Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

22 ratings

20

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

252.29 / 259.38Подкрепа & съпротива

Краткосрочен план

Weak Bearish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

49 / 374 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.